These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36298443)

  • 1. Outer Membrane Vesicles: An Emerging Vaccine Platform.
    Kashyap D; Panda M; Baral B; Varshney N; R S; Bhandari V; Parmar HS; Prasad A; Jha HC
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineering bacterial outer membrane vesicles as vaccine platform.
    Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
    Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants.
    Tan K; Li R; Huang X; Liu Q
    Front Microbiol; 2018; 9():783. PubMed ID: 29755431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.
    Rollier CS; Dold C; Marsay L; Linder A; Green CA; Sadarangani M; Norheim G; Derrick JP; Feavers IM; Maiden MCJ; Pollard AJ
    mSphere; 2022 Feb; 7(1):e0067421. PubMed ID: 35080470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designer outer membrane vesicles as immunomodulatory systems - Reprogramming bacteria for vaccine delivery.
    Gnopo YMD; Watkins HC; Stevenson TC; DeLisa MP; Putnam D
    Adv Drug Deliv Rev; 2017 May; 114():132-142. PubMed ID: 28501509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A "Plug-and-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-binding Domain.
    Feng R; Li GC; Jing HM; Liu C; Xue RY; Zou QM; Li HB
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35938846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses.
    Prior JT; Davitt C; Kurtz J; Gellings P; McLachlan JB; Morici LA
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Immune Response Induced by
    Barbosa MMF; Kanno AI; Barazzone GC; Rodriguez D; Pancakova V; Trentini M; Faquim-Mauro EL; Freitas AP; Khouri MI; Lobo-Silva J; Goncalves VM; Schenkman RPF; Tanizaki MM; Boraschi D; Malley R; Farias LP; Leite LCC
    Int J Nanomedicine; 2021; 16():7153-7168. PubMed ID: 34712047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors.
    Zheng K; Feng Y; Li L; Kong F; Gao J; Kong X
    Theranostics; 2024; 14(2):761-787. PubMed ID: 38169585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial outer membrane vesicles as a candidate tumor vaccine platform.
    Wang S; Guo J; Bai Y; Sun C; Wu Y; Liu Z; Liu X; Wang Y; Wang Z; Zhang Y; Hao H
    Front Immunol; 2022; 13():987419. PubMed ID: 36159867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial outer membrane vesicle-based cancer nanovaccines.
    Gao X; Feng Q; Wang J; Zhao X
    Cancer Biol Med; 2022 Sep; 19(9):1290-300. PubMed ID: 36172794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.
    Klouwens MJ; Salverda MLM; Trentelman JJ; Ersoz JI; Wagemakers A; Gerritzen MJH; van der Ley PA; Hovius JW
    Vaccine; 2021 Apr; 39(18):2561-2567. PubMed ID: 33812741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2.
    Park KS; Svennerholm K; Crescitelli R; Lässer C; Gribonika I; Andersson M; Boström J; Alalam H; Harandi AM; Farewell A; Lötvall J
    J Nanobiotechnology; 2023 May; 21(1):156. PubMed ID: 37208676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of
    Croia L; Boscato Sopetto G; Zanella I; Caproni E; Gagliardi A; Tamburini S; König E; Benedet M; Di Lascio G; Corbellari R; Grandi A; Tomasi M; Grandi G
    Membranes (Basel); 2023 Nov; 13(11):. PubMed ID: 37999368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes.
    Jalalifar S; Morovati Khamsi H; Hosseini-Fard SR; Karampoor S; Bajelan B; Irajian G; Mirzaei R
    Infect Agent Cancer; 2023 Jan; 18(1):3. PubMed ID: 36658631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
    Gerritzen MJH; Maas RHW; van den Ijssel J; van Keulen L; Martens DE; Wijffels RH; Stork M
    Microb Cell Fact; 2018 Oct; 17(1):157. PubMed ID: 30285743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.
    Bartolini E; Ianni E; Frigimelica E; Petracca R; Galli G; Berlanda Scorza F; Norais N; Laera D; Giusti F; Pierleoni A; Donati M; Cevenini R; Finco O; Grandi G; Grifantini R
    J Extracell Vesicles; 2013; 2():. PubMed ID: 24009891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.
    Sanders H; Feavers IM
    Expert Rev Vaccines; 2011 Mar; 10(3):323-34. PubMed ID: 21434800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.